Astra2 (2)
•
0 likes•202 views
The document is about a global, focused, integrated, innovation-driven biopharmaceutical business. Specifically: - It discovers, develops, manufactures and markets prescription medicines for six important healthcare areas including serious illnesses. - Its goal is to continue double-digit growth with emerging markets becoming 25% of sales by 2014 through focused strategies including accelerated investment in priority emerging markets like China and Mexico. - It has the scientific and operational capabilities needed to succeed globally as an innovative biopharmaceutical company.
Report
Share
Report
Share
Recommended
XPND Medical SA - Consulting Services
XPND Medical offers consulting services to healthcare companies that wishes to be ahead of the competition and expand their business in other markets.
Wil Philipsen - Fresh Idea Factory presentation
The document discusses Obli, a device that monitors and encourages fluid intake. It stimulates users with colors and sounds to drink more. An app tracks intake and integrates with health platforms. Studies show Obli increased fluid intake by 65% on average. It is currently used in several European countries in healthcare settings and by consumers. The company seeks strategic partners to help scale up production and marketing of Obli to further promote hydration and prevent health issues.
Transcript of CAGE presentation & Q+A
Luis Cantarell, EV-P head of Zone EMENA, presented at the 2015 CAGE conference in London on March 16 2015. He and Wan Ling Martello, CFO, answered questions afterwards.
Differentiating SMEs Strategies for Success
SMEs can differentiate themselves and achieve success through various strategies such as product development, market influence, marketing, pricing, quality customer service, and human resource strategies. Product development strategies include product diversification, modification, and revolutionary new products. Market influence strategies involve market penetration, development, and Ansoff's matrix. Key elements of a marketing strategy are the 5 Ps - product, price, place, promotion, and people. Pricing strategies include premium, penetration, economy, price skimming, and psychological pricing. Providing quality customer service and attracting top talent through competitive compensation and a positive work culture are also important strategies.
Luis Cantarell, EVP of Zone EMENA, presentes to 2015 CAGE conference in London
Luis Cantarell, Executuive Vice-President in charge of Nestlé Zone Europe, Middle East and North Africa, presents to the 2015 CAGE (Consumer Anylsts' Group Europe) on 'Translating the Nestlé roadmap into executional excellence'.
Francine Nieto Quintiles IMS Presentation
The global OTC market reached $112 billion in sales as of mid-2016, with developing regions driving most of the growth. Major trends include a shift toward health and wellness, the rise of connected consumers, and increasing interest in herbal and natural remedies. The document outlines routes to growth for OTC companies through innovation, geographic expansion, focus on high-growth categories, and potential M&A activity.
Ansoff matrix
The document discusses Ansoff's Matrix, which represents different options for sales growth through strategic marketing decisions. It outlines the two variables in the matrix - market and product. The four strategies presented are market penetration, market development, product development, and diversification. Market penetration involves selling more of existing products in existing markets and carries the lowest risk, while diversification, expanding into new markets with new products, poses the highest risk. The matrix helps identify areas a business could expand into, and managers must assess the costs, gains and risks of each strategic option.
Saleskipathshala : Business Growth Strategy With Ansoff Matrix - by Sanjay Singh
The SME CEO often thinks about further growth in business and grapples between existing products and existing markets on one hand and new products and new markets on the other. The Ansoff Matrix is a tool to assist all CEO’s in their choice between new and existing products as well as markets to move further in business.
Recommended
XPND Medical SA - Consulting Services
XPND Medical offers consulting services to healthcare companies that wishes to be ahead of the competition and expand their business in other markets.
Wil Philipsen - Fresh Idea Factory presentation
The document discusses Obli, a device that monitors and encourages fluid intake. It stimulates users with colors and sounds to drink more. An app tracks intake and integrates with health platforms. Studies show Obli increased fluid intake by 65% on average. It is currently used in several European countries in healthcare settings and by consumers. The company seeks strategic partners to help scale up production and marketing of Obli to further promote hydration and prevent health issues.
Transcript of CAGE presentation & Q+A
Luis Cantarell, EV-P head of Zone EMENA, presented at the 2015 CAGE conference in London on March 16 2015. He and Wan Ling Martello, CFO, answered questions afterwards.
Differentiating SMEs Strategies for Success
SMEs can differentiate themselves and achieve success through various strategies such as product development, market influence, marketing, pricing, quality customer service, and human resource strategies. Product development strategies include product diversification, modification, and revolutionary new products. Market influence strategies involve market penetration, development, and Ansoff's matrix. Key elements of a marketing strategy are the 5 Ps - product, price, place, promotion, and people. Pricing strategies include premium, penetration, economy, price skimming, and psychological pricing. Providing quality customer service and attracting top talent through competitive compensation and a positive work culture are also important strategies.
Luis Cantarell, EVP of Zone EMENA, presentes to 2015 CAGE conference in London
Luis Cantarell, Executuive Vice-President in charge of Nestlé Zone Europe, Middle East and North Africa, presents to the 2015 CAGE (Consumer Anylsts' Group Europe) on 'Translating the Nestlé roadmap into executional excellence'.
Francine Nieto Quintiles IMS Presentation
The global OTC market reached $112 billion in sales as of mid-2016, with developing regions driving most of the growth. Major trends include a shift toward health and wellness, the rise of connected consumers, and increasing interest in herbal and natural remedies. The document outlines routes to growth for OTC companies through innovation, geographic expansion, focus on high-growth categories, and potential M&A activity.
Ansoff matrix
The document discusses Ansoff's Matrix, which represents different options for sales growth through strategic marketing decisions. It outlines the two variables in the matrix - market and product. The four strategies presented are market penetration, market development, product development, and diversification. Market penetration involves selling more of existing products in existing markets and carries the lowest risk, while diversification, expanding into new markets with new products, poses the highest risk. The matrix helps identify areas a business could expand into, and managers must assess the costs, gains and risks of each strategic option.
Saleskipathshala : Business Growth Strategy With Ansoff Matrix - by Sanjay Singh
The SME CEO often thinks about further growth in business and grapples between existing products and existing markets on one hand and new products and new markets on the other. The Ansoff Matrix is a tool to assist all CEO’s in their choice between new and existing products as well as markets to move further in business.
Glaxo smith kline
GlaxoSmithKline (GSK) is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in Brentford, London.
Healthcare and Pharma Brands across APAC Nations
This document summarizes key insights from an issue of the IMS Asia-Pacific Insight Magazine. It discusses the burgeoning over-the-counter (OTC) drug market in Asia-Pacific, which has significantly outpaced global OTC growth for the past three years. Within Asia-Pacific, developed OTC markets like Australia, Japan, Singapore, and the Philippines have established norms of self-medication and OTC advertising. However, developing markets still have developing consumer mindsets and less accessibility. The document advocates understanding differences between developed and developing markets to effectively capture opportunities in the growing Asia-Pacific OTC market.
Strategic Management presentation for a Pharmaceutical Industry
The document provides an overview of Sanofi, a major global pharmaceutical company, including:
- Its operations in over 100 countries with over 100,000 employees and 19,300 scientists
- Its business entities and therapeutic expertise in the Philippines, focusing on cardiovascular diseases, diabetes, oncology, and other areas
- Details on its organizational structure, vision and mission statements, research and development process, product types, supply chain, and performance in the diabetes drug category market
Parkville strategic project final-converted
Parkville Pharmaceuticals is an Egyptian pharmaceutical company established in 2006 with headquarters in Alexandria and Cairo. It has grown from a small local company to a multinational company with over 175 employees and a diverse product range including pharmaceuticals, cosmeceuticals, dietary supplements, and medical devices. Parkville's vision is to be a key player in healthcare in the Middle East and Africa by 2025 and expand globally thereafter. Its mission is to have a strong presence in the Egyptian market and gain momentum in other fast-growing markets through innovative, high-quality, affordable products. A PESTEL analysis identifies opportunities and threats in the company's external environment.
Ranbaxycompanyprofile
Ranbaxy is India's largest pharmaceutical company with a global footprint in 43 countries. It has a diverse product portfolio and strong R&D capabilities. In 2011, Ranbaxy recorded global sales of $2.1 billion, with emerging and developed markets each contributing around 47% and 46% respectively. Ranbaxy aims to grow organically and inorganically, focusing on high-growth areas like biologics and injectables. It also has a hybrid business model through its alliance with Daiichi Sankyo to create an innovator and generic powerhouse. Ranbaxy emphasizes R&D as a strategic priority and has over 1,200 personnel dedicated to research.
Shared Value in the Pharmaceutical Industry
This document provides an overview of Medstar Limited, an Australian pharmaceutical company. It discusses Medstar's current operations, which are focused on developed markets. It notes Medstar previously failed when trying to enter emerging markets in Cambodia and Vietnam. The document identifies opportunities for Medstar to improve its strategy and create shared value in emerging Asian markets by addressing social problems through innovative business models. It analyzes weaknesses in Medstar's current value chain and areas that need reassessment, such as research and development and marketing/sales, to better position the company for future growth opportunities.
Muhammad ehsan 19576 report (3)
Getz Pharmaceutical is Pakistan's largest branded generic pharmaceutical company. It has a diverse product portfolio and fast-growing sales force. The company sees opportunities in expanding into untapped territories and growing disease categories like diabetes. However, it faces threats from changing regulations, cost pressures, and new entrants. Getz aims to address issues and seize opportunities by strengthening its sales training, considering technology to aid its workforce, and exploring partnerships or acquisitions.
Cbm company profile v1
CrossBay Medical was founded to leverage over 50 years of combined experience in the medical device field. Their mission is to develop and manufacture cost-effective medical products and commercialize them globally. They aim to provide affordable healthcare solutions, especially in emerging markets. CrossBay Medical partners with suppliers and innovators to help them obtain regulatory approvals, assess markets, and distribute their products through CrossBay's global network.
Differentiation strategies for the generic industrry
This document outlines a workshop on differentiation strategies for generic drug companies. The workshop covers current differentiation approaches, challenges to differentiation, ideas for potential strategies, and future trends. Session 1 introduces the topic and reviews examples like PiSA Farmaceutica's integrated healthcare approach. Session 2 discusses challenges around resources, expertise, and changing organizations. Session 3 generates ideas around product leadership, operational excellence, and customer intimacy. Session 4 speculates on future industry shifts like prevention-focused care and personalized medicine.
Marketing Plan (Tractor Drug Company)
Tractor Drugs, an Indian pharmaceutical company, wants to expand into Southeast and West Asian markets. It has developed new life-saving drugs and seeks to penetrate these regions through a phased marketing plan. The plan involves distributing products through local warehouses, targeting hospitals and retailers, and promoting the brand's high quality yet affordable drugs and services through various online and offline advertising methods. The company aims to position itself as a reliable source for critical medications while keeping costs low.
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within 3 to 5 years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. With so many revenue-producing drugs going off patent, companies are facing large holes in their balance sheets and sales that are increasingly slow.
Plus, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.
More and more, companies are expecting marketers to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launch, companies must engage in comprehensive pre-launch planning.
In this report we analyze why launch is increasingly important, the issues involved in pre-launch planning, including key organizational strategies, marketing tactics, regulatory considerations, global issues, and methods for ensuring the most effective plans.
johnson n johnson
Johnson & Johnson is a global healthcare company founded in 1886 in New Jersey. It has over 114,000 employees worldwide and sells its products in 175 countries. The company's segments include consumer health, pharmaceuticals, and medical devices. It has a strong presence in India dating back to 1947. Johnson & Johnson is guided by its credo which outlines priorities for customers, employees, communities, and shareholders. The company's strategic capabilities include its diverse product portfolio and global presence.
EVA pharma document
This document provides an overview of Eva Pharmaceuticals and its supply chain. It discusses how Eva Pharmaceuticals was established in 1997 as one of Egypt's leading pharmaceutical companies. It also outlines some of Eva Pharmaceuticals' key logistical activities, including quality control processes. The document summarizes the pharmaceutical industry in Egypt and how government regulations have affected it. It provides details on Eva Pharmaceuticals' target customers and corporate social responsibility initiatives through the Armanious Foundation.
Rikas Investment Group's Corporate Brochure
The document promotes investment opportunities in life-support areas such as healthcare and agriculture through the Rikas Investment Group. The Group aims to unleash European investment potential in Ukraine by opening an IVF center, managing generic drug supplies, supplying goods to Gaza, and opening dental clinics. It highlights the experience and qualifications of the management team and outlines strategic directions and key investment indicators for the IVF center project.
S du Preez Jan 2016
The document provides a summary and professional experience of Shireen du Preez, including over 10 years of experience in strategic marketing roles in the healthcare industry focusing on product management, sales, and business development for companies in South Africa. She has a proven track record of successfully launching new products and growing market share across therapeutic areas such as oncology, hematology, and pain management.
Our priority is to access more patients we need to adjust prices accordingly
1) Janssen's chairman discussed the company's strategies for growth in India, including launching several new medicines to address unmet needs, especially for tuberculosis, hepatitis C, diabetes, and other diseases.
2) To increase access to patients, Janssen may adopt tiered pricing structures in India, adjusting prices based on local healthcare resources and disease prevalence.
3) Intellectual property protection is important for innovation-based companies like Janssen to invest in developing new therapies, and while IP protection was a concern in India, the situation seems to be improving.
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
This document discusses how creativity can boost performance in pharmaceutical companies. It addresses why creativity is important, how to craft a creative strategy, and how to build a creativity-driven organization.
Some key points include:
- Creativity stimulates discoveries, inventions and innovations that can result in new products and services with potential value. It involves thinking beyond conventional knowledge.
- To cope with changing competitive pressures, pharmaceutical companies must develop creative business models and strategies that reduce costs and offer better value.
- Crafting a creative strategy involves identifying business opportunities where the company has a strong competitive advantage using tools like the strategic canvas. "Blue ocean" strategies create new market spaces to make competition irrelevant.
-
Top generic pharma companies in india ppt
I have provided the analyzed list of Top Generic Pharma Companies in India. Check blog and choose right generic pharma companies franchise for PCD business. For more information visit http://www.pharmaadda.in/top-generic-pharma-companies-in-india
Sandoz Company Presentation
Sandoz reached 520 million patients worldwide in 2015 and aims to reach one billion patients by expanding access to medicine. The presentation discusses the global challenge of access to healthcare, with over 2 billion people unable to access needed medicines. Sandoz is uniquely positioned within Novartis to help solve the access challenge through its broad portfolio, focus on priority markets, and leadership in generics, biosimilars, and anti-infectives.
Kybora EM_ABI 2016
The document discusses trends in life science investing globally. It notes that while US and European healthcare IPO issuance and market volatility has fluctuated between 2010-2016, overall investment in healthcare IPOs and M&A transactions has generally increased. The document then outlines trends showing increased investment in biotech and life sciences globally, including rising investments in China and more venture capital going to biopharma companies in their Series A rounds. It concludes that given increasing medical spending, longer life expectancies and rapid innovation, it is a good time to start new life sciences businesses.
Cleades robinson:The Diplomat is Blue
Cleades Robinson, a respected leader in Philadelphia's police force, is known for his diplomatic and tactful approach, fostering a strong community rapport.
More Related Content
Similar to Astra2 (2)
Glaxo smith kline
GlaxoSmithKline (GSK) is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in Brentford, London.
Healthcare and Pharma Brands across APAC Nations
This document summarizes key insights from an issue of the IMS Asia-Pacific Insight Magazine. It discusses the burgeoning over-the-counter (OTC) drug market in Asia-Pacific, which has significantly outpaced global OTC growth for the past three years. Within Asia-Pacific, developed OTC markets like Australia, Japan, Singapore, and the Philippines have established norms of self-medication and OTC advertising. However, developing markets still have developing consumer mindsets and less accessibility. The document advocates understanding differences between developed and developing markets to effectively capture opportunities in the growing Asia-Pacific OTC market.
Strategic Management presentation for a Pharmaceutical Industry
The document provides an overview of Sanofi, a major global pharmaceutical company, including:
- Its operations in over 100 countries with over 100,000 employees and 19,300 scientists
- Its business entities and therapeutic expertise in the Philippines, focusing on cardiovascular diseases, diabetes, oncology, and other areas
- Details on its organizational structure, vision and mission statements, research and development process, product types, supply chain, and performance in the diabetes drug category market
Parkville strategic project final-converted
Parkville Pharmaceuticals is an Egyptian pharmaceutical company established in 2006 with headquarters in Alexandria and Cairo. It has grown from a small local company to a multinational company with over 175 employees and a diverse product range including pharmaceuticals, cosmeceuticals, dietary supplements, and medical devices. Parkville's vision is to be a key player in healthcare in the Middle East and Africa by 2025 and expand globally thereafter. Its mission is to have a strong presence in the Egyptian market and gain momentum in other fast-growing markets through innovative, high-quality, affordable products. A PESTEL analysis identifies opportunities and threats in the company's external environment.
Ranbaxycompanyprofile
Ranbaxy is India's largest pharmaceutical company with a global footprint in 43 countries. It has a diverse product portfolio and strong R&D capabilities. In 2011, Ranbaxy recorded global sales of $2.1 billion, with emerging and developed markets each contributing around 47% and 46% respectively. Ranbaxy aims to grow organically and inorganically, focusing on high-growth areas like biologics and injectables. It also has a hybrid business model through its alliance with Daiichi Sankyo to create an innovator and generic powerhouse. Ranbaxy emphasizes R&D as a strategic priority and has over 1,200 personnel dedicated to research.
Shared Value in the Pharmaceutical Industry
This document provides an overview of Medstar Limited, an Australian pharmaceutical company. It discusses Medstar's current operations, which are focused on developed markets. It notes Medstar previously failed when trying to enter emerging markets in Cambodia and Vietnam. The document identifies opportunities for Medstar to improve its strategy and create shared value in emerging Asian markets by addressing social problems through innovative business models. It analyzes weaknesses in Medstar's current value chain and areas that need reassessment, such as research and development and marketing/sales, to better position the company for future growth opportunities.
Muhammad ehsan 19576 report (3)
Getz Pharmaceutical is Pakistan's largest branded generic pharmaceutical company. It has a diverse product portfolio and fast-growing sales force. The company sees opportunities in expanding into untapped territories and growing disease categories like diabetes. However, it faces threats from changing regulations, cost pressures, and new entrants. Getz aims to address issues and seize opportunities by strengthening its sales training, considering technology to aid its workforce, and exploring partnerships or acquisitions.
Cbm company profile v1
CrossBay Medical was founded to leverage over 50 years of combined experience in the medical device field. Their mission is to develop and manufacture cost-effective medical products and commercialize them globally. They aim to provide affordable healthcare solutions, especially in emerging markets. CrossBay Medical partners with suppliers and innovators to help them obtain regulatory approvals, assess markets, and distribute their products through CrossBay's global network.
Differentiation strategies for the generic industrry
This document outlines a workshop on differentiation strategies for generic drug companies. The workshop covers current differentiation approaches, challenges to differentiation, ideas for potential strategies, and future trends. Session 1 introduces the topic and reviews examples like PiSA Farmaceutica's integrated healthcare approach. Session 2 discusses challenges around resources, expertise, and changing organizations. Session 3 generates ideas around product leadership, operational excellence, and customer intimacy. Session 4 speculates on future industry shifts like prevention-focused care and personalized medicine.
Marketing Plan (Tractor Drug Company)
Tractor Drugs, an Indian pharmaceutical company, wants to expand into Southeast and West Asian markets. It has developed new life-saving drugs and seeks to penetrate these regions through a phased marketing plan. The plan involves distributing products through local warehouses, targeting hospitals and retailers, and promoting the brand's high quality yet affordable drugs and services through various online and offline advertising methods. The company aims to position itself as a reliable source for critical medications while keeping costs low.
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within 3 to 5 years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. With so many revenue-producing drugs going off patent, companies are facing large holes in their balance sheets and sales that are increasingly slow.
Plus, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.
More and more, companies are expecting marketers to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launch, companies must engage in comprehensive pre-launch planning.
In this report we analyze why launch is increasingly important, the issues involved in pre-launch planning, including key organizational strategies, marketing tactics, regulatory considerations, global issues, and methods for ensuring the most effective plans.
johnson n johnson
Johnson & Johnson is a global healthcare company founded in 1886 in New Jersey. It has over 114,000 employees worldwide and sells its products in 175 countries. The company's segments include consumer health, pharmaceuticals, and medical devices. It has a strong presence in India dating back to 1947. Johnson & Johnson is guided by its credo which outlines priorities for customers, employees, communities, and shareholders. The company's strategic capabilities include its diverse product portfolio and global presence.
EVA pharma document
This document provides an overview of Eva Pharmaceuticals and its supply chain. It discusses how Eva Pharmaceuticals was established in 1997 as one of Egypt's leading pharmaceutical companies. It also outlines some of Eva Pharmaceuticals' key logistical activities, including quality control processes. The document summarizes the pharmaceutical industry in Egypt and how government regulations have affected it. It provides details on Eva Pharmaceuticals' target customers and corporate social responsibility initiatives through the Armanious Foundation.
Rikas Investment Group's Corporate Brochure
The document promotes investment opportunities in life-support areas such as healthcare and agriculture through the Rikas Investment Group. The Group aims to unleash European investment potential in Ukraine by opening an IVF center, managing generic drug supplies, supplying goods to Gaza, and opening dental clinics. It highlights the experience and qualifications of the management team and outlines strategic directions and key investment indicators for the IVF center project.
S du Preez Jan 2016
The document provides a summary and professional experience of Shireen du Preez, including over 10 years of experience in strategic marketing roles in the healthcare industry focusing on product management, sales, and business development for companies in South Africa. She has a proven track record of successfully launching new products and growing market share across therapeutic areas such as oncology, hematology, and pain management.
Our priority is to access more patients we need to adjust prices accordingly
1) Janssen's chairman discussed the company's strategies for growth in India, including launching several new medicines to address unmet needs, especially for tuberculosis, hepatitis C, diabetes, and other diseases.
2) To increase access to patients, Janssen may adopt tiered pricing structures in India, adjusting prices based on local healthcare resources and disease prevalence.
3) Intellectual property protection is important for innovation-based companies like Janssen to invest in developing new therapies, and while IP protection was a concern in India, the situation seems to be improving.
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
This document discusses how creativity can boost performance in pharmaceutical companies. It addresses why creativity is important, how to craft a creative strategy, and how to build a creativity-driven organization.
Some key points include:
- Creativity stimulates discoveries, inventions and innovations that can result in new products and services with potential value. It involves thinking beyond conventional knowledge.
- To cope with changing competitive pressures, pharmaceutical companies must develop creative business models and strategies that reduce costs and offer better value.
- Crafting a creative strategy involves identifying business opportunities where the company has a strong competitive advantage using tools like the strategic canvas. "Blue ocean" strategies create new market spaces to make competition irrelevant.
-
Top generic pharma companies in india ppt
I have provided the analyzed list of Top Generic Pharma Companies in India. Check blog and choose right generic pharma companies franchise for PCD business. For more information visit http://www.pharmaadda.in/top-generic-pharma-companies-in-india
Sandoz Company Presentation
Sandoz reached 520 million patients worldwide in 2015 and aims to reach one billion patients by expanding access to medicine. The presentation discusses the global challenge of access to healthcare, with over 2 billion people unable to access needed medicines. Sandoz is uniquely positioned within Novartis to help solve the access challenge through its broad portfolio, focus on priority markets, and leadership in generics, biosimilars, and anti-infectives.
Kybora EM_ABI 2016
The document discusses trends in life science investing globally. It notes that while US and European healthcare IPO issuance and market volatility has fluctuated between 2010-2016, overall investment in healthcare IPOs and M&A transactions has generally increased. The document then outlines trends showing increased investment in biotech and life sciences globally, including rising investments in China and more venture capital going to biopharma companies in their Series A rounds. It concludes that given increasing medical spending, longer life expectancies and rapid innovation, it is a good time to start new life sciences businesses.
Similar to Astra2 (2) (20)
Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical Industry
Differentiation strategies for the generic industrry
Differentiation strategies for the generic industrry
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
Our priority is to access more patients we need to adjust prices accordingly
Our priority is to access more patients we need to adjust prices accordingly
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Recently uploaded
Cleades robinson:The Diplomat is Blue
Cleades Robinson, a respected leader in Philadelphia's police force, is known for his diplomatic and tactful approach, fostering a strong community rapport.
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
The world of blockchain and decentralized technologies is about to witness a groundbreaking event. ZKsync, the pioneering Ethereum Layer 2 network, has announced the highly anticipated airdrop of its native token, ZK. This move marks a significant milestone in the protocol's journey, empowering the community to take the reins and shape the future of this revolutionary ecosystem.
UnityNet World Environment Day Abraham Project 2024 Press Release
June 12, 2024 UnityNet International (#UNI) World Environment Day Abraham Project 2024 Press Release from Markham / Mississauga, Ontario in the, Greater Tkaronto Bioregion, Canada in the North American Great Lakes Watersheds of North America (Turtle Island).
Methanex Investor Presentation - April 2024
Methanex is the world's largest producer and supplier of methanol. We create value through our leadership in the global production, marketing and delivery of methanol to customers. View our latest Investor Presentation for more details.
快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样
学校原件一模一样【微信：741003700 】《(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
ppt-namibia-worldeconomy-standardbank.ppt
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4study presented by a Big 4
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
Understanding-the-E-Way-Bill-A-Digital-Transformation-in-Logistics.pptx
The E-Way Bill revolutionizes logistics by digitizing the documentation of goods transport, ensuring transparency, tax compliance, and streamlined processes. This mandatory, electronic system reduces delays, enhances accountability, and combats tax evasion, benefiting businesses and authorities alike. Embrace the E-Way Bill for efficient, reliable transportation operations.
Recently uploaded (14)
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
UnityNet World Environment Day Abraham Project 2024 Press Release
UnityNet World Environment Day Abraham Project 2024 Press Release
Mandalay Resouces June 2024 Investor Relations PPT
Mandalay Resouces June 2024 Investor Relations PPT
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
Understanding-the-E-Way-Bill-A-Digital-Transformation-in-Logistics.pptx
Understanding-the-E-Way-Bill-A-Digital-Transformation-in-Logistics.pptx
Astra2 (2)
- 1. is a global, focused, integrated,innovation-driven, biopharmaceutical business.
- 2. is a global, focused, integrated,innovation-driven, biopharmaceutical business.
- 3. “We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses.”
- 4. A global, focused, integrated, innovation-driven, biopharmaceutical business.
- 5. •A research based Pharma is an attractive business for the long-term. -Sector can grow at least in line with real GDP growth long term -The sector‘s best players will earn attractive returns on capital •AZ has the requisite capabilities to succeed -Scientific capacity for innovation in small molecules & biologics -Global reach & scale -Sales & marketing excellence -Operational execution A global, focused, integrated, innovation-driven, biopharmaceutical business.
- 6. A global, focused, integrated, innovation-driven, biopharmaceutical business.
- 7. Making the Most meaning difference to patient health through great medicines Manage for long-term shareholder Our values Our values A global, focused, integrated, innovation-driven, biopharmaceutical business.
- 8. Their goal is to continue double-digit growth, with emerging markets becoming ~25% of AZ sales by 2014. A global, focused, integrated, innovation-driven, biopharmaceutical business.
- 9. Their strategy in emerging markets has three elements. A global, focused, integrated, innovation-driven, biopharmaceutical business.
- 10. Clear and focused strategy for emerging markets Category of Market Approach Example Markets Top priority Invest for accelerated growth now China Mexico Second wave Create the foundation for medium term growth Brazil Central and Eastern Europe Maintain presence; no major investment short term Holding Pattern India Argentina A global, focused, integrated, innovation-driven, biopharmaceutical business.
- 11. AZ were the 1st to invest in China, the largest Emerging Market opportunity. We have been successful at catching up quickly in other markets. AZ have built strong local organisations to successfully manage local market dynamics. . We support our local organisations with the best practice of our global capabilities. We have a diverse portfolio of relevant products. . A global, focused, integrated, innovation-driven, biopharmaceutical business.